|
1
|
Ewertz M: Influence of non-contraceptive
exogenous and endogenous sex hormones on breast cancer risk in
Denmark. Int J Cancer. 42:832–838. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nass SJ and Davidson NE: The biology of
breast cancer. Hematol Oncol Clin North Am. 13:311–332. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okobia MN and Bunker CH: Estrogen
metabolism and breast cancer risk - a review. Afr J Reprod Health.
10:13–25. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meyer F, Brown JB, Morrison AS and
MacMahon B: Endogenous sex hormones, prolactin, and breast cancer
in premenopausal women. J Natl Cancer Inst. 77:613–616.
1986.PubMed/NCBI
|
|
5
|
Key T, Appleby P, Barnes I and Reeves G;
Endogenous Hormones and Breast Cancer Collaborative Group:
Endogenous sex hormones and breast cancer in postmenopausal women:
reanalysis of nine prospective studies. J Natl Cancer Inst.
94:606–616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Onland-Moret NC, Kaaks R, van Noord PA, et
al: Urinary endogenous sex hormone levels and the risk of
postmenopausal breast cancer. Br J Cancer. 88:1394–1399. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Biggar RJ: Molecular pathways: digoxin use
and estrogen-sensitive cancers - risks and possible therapeutic
implications. Clin Cancer Res. 18:2133–2137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bulun SE, Lin Z, Imir G, et al: Regulation
of aromatase expression in estrogen-responsive breast and uterine
disease: from bench to treatment. Pharmacol Rev. 57:359–383. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Simpson ER and Davis SR: Minireview:
aromatase and the regulation of estrogen biosynthesis - some new
perspectives. Endocrinology. 142:4589–4594. 2001.PubMed/NCBI
|
|
10
|
O'Neill JS, Elton RA and Miller WR:
Aromatase activity in adipose tissue from breast quadrants: a link
with tumour site. Br Med J (Clin Res Ed). 296:741–743. 1988.
View Article : Google Scholar
|
|
11
|
Bulun SE, Price TM, Aitken J, Mahendroo MS
and Simpson ER: A link between breast cancer and local estrogen
biosynthesis suggested by quantification of breast adipose tissue
aromatase cytochrome P450 transcripts using competitive polymerase
chain reaction after reverse transcription. J Clin Endocrinol
Metab. 77:1622–1628. 1993.PubMed/NCBI
|
|
12
|
Harada N: Aberrant expression of aromatase
in breast cancer tissues. J Steroid Biochem Mol Biol. 61:175–184.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sasano H and Harada N: Intratumoral
aromatase in human breast, endometrial, and ovarian malignancies.
Endocr Rev. 19:593–607. 1998.PubMed/NCBI
|
|
14
|
Morales L, Neven P and Paridaens R:
Choosing between an aromatase inhibitor and tamoxifen in the
adjuvant setting. Curr Opin Oncol. 17:559–565. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Umar A, Dunn BK and Greenwald P: Future
directions in cancer prevention. Nat Rev Cancer. 12:835–848. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tomao F, Spinelli G, Vici P, et al:
Current role and safety profile of aromatase inhibitors in early
breast cancer. Expert Rev Anticancer Ther. 11:1253–1263. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamat A, Hinshelwood MM, Murry BA and
Mendelson CR: Mechanisms in tissue-specific regulation of estrogen
biosynthesis in humans. Trends Endocrinol Metab. 13:122–128. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bulun SE, Sebastian S, Takayama K, Suzuki
T, Sasano H and Shozu M: The human CYP19 (aromatase P450) gene:
update on physiologic roles and genomic organization of promoters.
J Steroid Biochem Mol Biol. 86:219–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stocco C: Tissue physiology and pathology
of aromatase. Steroids. 77:27–35. 2012. View Article : Google Scholar :
|
|
20
|
Meng L, Zhou J, Sasano H, Suzuki T,
Zeitoun KM and Bulun SE: Tumor necrosis factor alpha and
interleukin 11 secreted by malignant breast epithelial cells
inhibit adipocyte differentiation by selectively down-regulating
CCAAT/enhancer binding protein alpha and peroxisome
proliferator-activated receptor gamma: mechanism of desmoplastic
reaction. Cancer Res. 61:2250–2255. 2001.PubMed/NCBI
|
|
21
|
Zhou J, Gurates B, Yang S, Sebastian S and
Bulun SE: Malignant breast epithelial cells stimulate aromatase
expression via promoter II in human adipose fibroblasts: an
epithelial-stromal interaction in breast tumors mediated by
CCAAT/enhancer binding protein beta. Cancer Res. 61:2328–2334.
2001.PubMed/NCBI
|
|
22
|
Purohit A, Ghilchik MW, Duncan L, et al:
Aromatase activity and interleukin-6 production by normal and
malignant breast tissues. J Clin Endocrinol Metab. 80:3052–3058.
1995.PubMed/NCBI
|
|
23
|
Schrey MP and Patel KV: Prostaglandin
E2 production and metabolism in human breast cancer
cells and breast fibroblasts. Regulation by inflammatory mediators.
Br J Cancer. 72:1412–1419. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang SH, Liu CH, Conway R, et al: Role of
prostaglandin E2-dependent angiogenic switch in cyclooxygenase
2-induced breast cancer progression. Proc Natl Acad Sci USA.
101:591–596. 2004. View Article : Google Scholar :
|
|
25
|
Zhao Y, Agarwal VR, Mendelson CR and
Simpson ER: Estrogen biosynthesis proximal to a breast tumor is
stimulated by PGE2 via cyclic AMP, leading to activation
of promoter II of the CYP19 (aromatase) gene. Endocrinology.
137:5739–5742. 1996.PubMed/NCBI
|
|
26
|
Chen D, Reierstad S, Lin Z, et al:
Prostaglandin E2 induces breast cancer related aromatase
promoters via activation of p38 and c-Jun NH-terminal kinase in
adipose fibroblasts. Cancer Res. 67:8914–8922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bulun SE, Lin Z, Zhao H, et al: Regulation
of aromatase expression in breast cancer tissue. Ann NY Acad Sci.
1155:121–131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen D, Reierstad S, Fang F and Bulun SE:
JunD and JunB integrate prostaglandin E activation of breast
cancer-associated proximal aromatase promoters. Mol Endocrinol.
25:767–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Avvisato CL, Yang X, Shah S, et al:
Mechanical force modulates global gene expression and beta-catenin
signaling in colon cancer cells. J Cell Sci. 120:2672–2682. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shyy JY and Chien S: Role of integrins in
endothelial mechanosensing of shear stress. Circ Res. 91:769–775.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Alenghat FJ and Ingber DE:
Mechanotransduction: all signals point to cytoskeleton, matrix, and
integrins. Sci STKE. 119:pe62002.
|
|
32
|
Lopez JI, Mouw JK and Weaver VM:
Biomechanical regulation of cell orientation and fate. Oncogene.
27:6981–6993. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nelson CM and Bissell MJ: Of extracellular
matrix, scaffolds, and signaling: tissue architecture regulates
development, homeostasis, and cancer. Annu Rev Cell Dev Biol.
22:287–309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Provenzano PP and Keely PJ: Mechanical
signaling through the cytoskeleton regulates cell proliferation by
coordinated focal adhesion and Rho GTPase signaling. J Cell Sci.
124:1195–1205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Paszek MJ and Weaver VM: The tension
mounts: mechanics meets morphogenesis and malignancy. J Mammary
Gland Biol Neoplasia. 9:325–342. 2004. View Article : Google Scholar
|
|
36
|
Ingber DE: Can cancer be reversed by
engineering the tumor microenvironment? Semin Cancer Biol.
18:356–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Le Beyec J, Xu R, Lee SY, et al: Cell
shape regulates global histone acetylation in human mammary
epithelial cells. Exp Cell Res. 313:3066–3075. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wiseman BS and Werb Z: Stromal effects on
mammary gland development and breast cancer. Science.
296:1046–1049. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Plodinec M and Schoenenberger CA: Spatial
organization acts on cell signaling: how physical force contributes
to the development of cancer. Breast Cancer Res. 12:3082010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McCormack VA and dos Santos Silva I:
Breast density and parenchymal patterns as markers of breast cancer
risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev.
15:1159–1169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Boyd NF, Martin LJ, Stone J, Greenberg C,
Minkin S and Yaffe MJ: Mammographic densities as a marker of human
breast cancer risk and their use in chemoprevention. Curr Oncol
Rep. 3:314–321. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hawes D, Downey S, Pearce CL, et al: Dense
breast stromal tissue shows greatly increased concentration of
breast epithelium but no increase in its proliferative activity.
Breast Cancer Res. 8:R242006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo YP, Martin LJ, Hanna W, et al: Growth
factors and stromal matrix proteins associated with mammographic
densities. Cancer Epidemiol Biomarkers Prev. 10:243–248.
2001.PubMed/NCBI
|
|
44
|
Alowami S, Troup S, Al-Haddad S,
Kirkpatrick I and Watson PH: Mammographic density is related to
stroma and stromal proteoglycan expression. Breast Cancer Res.
5:R129–R135. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li T, Sun L, Miller N, et al: The
association of measured breast tissue characteristics with
mammographic density and other risk factors for breast cancer.
Cancer Epidemiol Biomarkers Prev. 14:343–349. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Provenzano PP, Inman DR, Eliceiri KW, et
al: Collagen density promotes mammary tumor initiation and
progression. BMC Med. 6:112008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Leitinger B and Hohenester E: Mammalian
collagen receptors. Matrix Biol. 26:146–155. 2007. View Article : Google Scholar
|
|
48
|
Shintani Y, Fukumoto Y, Chaika N, Svoboda
R, Wheelock MJ and Johnson KR: Collagen I-mediated up-regulation of
N-cadherin requires cooperative signals from integrins and
discoidin domain receptor 1. J Cell Biol. 180:1277–1289. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shintani Y, Maeda M, Chaika N, Johnson KR
and Wheelock MJ: Collagen I promotes epithelial-to-mesenchymal
transition in lung cancer cells via transforming growth factor-beta
signaling. Am J Respir Cell Mol Biol. 38:95–104. 2008. View Article : Google Scholar
|
|
50
|
Shintani Y, Hollingsworth MA, Wheelock MJ
and Johnson KR: Collagen I promotes metastasis in pancreatic cancer
by activating c-Jun NH2-terminal kinase 1 and
up-regulating N-cadherin expression. Cancer Res. 66:11745–11753.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shintani Y, Wheelock MJ and Johnson KR:
Phosphoinositide-3 kinase-Rac1-c-Jun NH -terminal kinase signaling
mediates collagen I-induced cell scattering and up-regulation of
N-cadherin expression in mouse mammary epithelial cells. Mol Biol
Cell. 17:2963–2975. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wheelock MJ and Johnson KR:
Cadherin-mediated cellular signaling. Curr Opin Cell Biol.
15:509–514. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Plant AL, Bhadriraju K, Spurlin TA and
Elliott JT: Cell response to matrix mechanics: focus on collagen.
Biochim Biophys Acta. 1793:893–902. 2009. View Article : Google Scholar
|
|
54
|
Zhu X and Assoian RK: Integrin-dependent
activation of MAP kinase: a link to shape-dependent cell
proliferation. Mol Biol Cell. 6:273–282. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang L, Bewick M and Lafrenie RM: Role of
Raf-1 and FAK in cell density-dependent regulation of
integrin-dependent activation of MAP kinase. Carcinogenesis.
23:1251–1258. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ghosh S, Choudary A, Musi N, Hu Y and Li
R: IKKbeta mediates cell shape-induced aromatase expression and
estrogen biosynthesis in adipose stromal cells. Mol Endocrinol.
23:662–670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lee EY, Parry G and Bissell MJ: Modulation
of secreted proteins of mouse mammary epithelial cells by the
collagenous substrata. J Cell Biol. 98:146–155. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kass L, Erler JT, Dembo M and Weaver VM:
Mammary epithelial cell: influence of extracellular matrix
composition and organization during development and tumorigenesis.
Int J Biochem Cell Biol. 39:1987–1994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ghosh S, Wu Y, Li R and Hu Y: Jun proteins
modulate the ovary-specific promoter of aromatase gene in ovarian
granulosa cells via a cAMP-responsive element. Oncogene.
24:2236–2246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hu YF and Li R: JunB potentiates function
of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated
interaction. Genes Dev. 16:1509–1517. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Basson MD: An intracellular signal pathway
that regulates cancer cell adhesion in response to extracellular
forces. Cancer Res. 68:2–4. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Brancaccio M, Hirsch E, Notte A,
Selvetella G, Lembo G and Tarone G: Integrin signalling: the
tug-of-war in heart hypertrophy. Cardiovasc Res. 70:422–433. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Häcker H and Karin M: Regulation and
function of IKK and IKK-related kinases. Sci STKE.
357:re132006.
|
|
64
|
Bai D, Ueno L and Vogt PK: Akt-mediated
regulation of NFkappaB and the essentialness of NFkappaB for the
oncogenicity of PI3K and Akt. Int J Cancer. 125:2863–2870. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Staal SP, Hartley JW and Rowe WP:
Isolation of transforming murine leukemia viruses from mice with a
high incidence of spontaneous lymphoma. Proc Natl Acad Sci USA.
74:3065–3067. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Staal SP: Molecular cloning of the akt
oncogene and its human homologues AKT1 and AKT2: amplification of
AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci
USA. 84:5034–5037. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yang ZZ, Tschopp O, Baudry A, Dümmler B,
Hynx D and Hemmings BA: Physiological functions of protein kinase
B/Akt. Biochem Soc Trans. 32:350–354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bulun SE, Chen D, Lu M, et al: Aromatase
excess in cancers of breast, endometrium and ovary. J Steroid
Biochem Mol Biol. 106:81–96. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Baum M, Budzar AU, Cuzick J, et al:
Anastrozole alone or in combination with tamoxifen versus tamoxifen
alone for adjuvant treatment of postmenopausal women with early
breast cancer: first results of the ATAC randomised trial. Lancet.
359:2131–2139. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Demura M and Bulun SE: CpG dinucleotide
methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated
aromatase activity. Mol Cell Endocrinol. 283:127–132. 2008.
View Article : Google Scholar : PubMed/NCBI
|
